A Randomized Optical Coherence Tomography Study of Coronary Stent Strut Coverage and Luminal Protrusion With Rapamycin-Eluting Stents

JACC: Cardiovascular Interventions

Volumn 2, Issue 5, 2009, Pages 437-444

  Moore, Philip ^a   Barlis, Peter ^a   Spiro, Jonathan ^a   Ghimire, Gopal ^a   Roughton, Michael ^a   Di Mario, Carlo ^a   Wallis, William ^a   Ilsley, Charles ^a   Mitchell, Andrew ^a   Mason, Mark ^a   Kharbanda, Rajesh ^a   Vincent, Peter ^b   Sherwin, Spencer ^b   Dalby, Miles ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

optical coherence tomography; stent thrombosis; stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; POLYMER; RAPAMYCIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; EQUIPMENT DESIGN; FEMALE; HUMAN; IN-STENT RESTENOSIS; LOADING DRUG DOSE; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; CONFIDENCE INTERVAL; CORONARY BLOOD VESSEL; CORONARY RESTENOSIS; DRUG EFFECTS; MIDDLE AGED; PATHOLOGY; VASCULAR ENDOTHELIUM;

CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; POLYMERS; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 65549099770     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.01.010     Document Type: Article

References (21)

1. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Weisz G., Leon M.B., Holmes Jr. D.R., et al. Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial. J Am Coll Cardiol 47 (2006) 1350-1355
3. Finn A.V., Joner M., Nakazawa G., et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
4. Daemen J., Wenaweser P., Tsuchida K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
5. Bavry A.A., Kumbhani D.J., Helton T.J., Borek P.P., Mood G.R., and Bhatt D.L. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 119 (2006) 1056-1061
6. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
7. Yamaguci T., Terashima M., Akasaka T., et al. Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. Am J Cardiol 101 (2008) 562-567
8. Suzuki Y., Ikeno F., Koizumi T., et al. In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation. J Am Coll Cardiol Intv 1 (2008) 168-173
9. Matsumoto D., Shite J., Shinke T., et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 8 (2007) 961-967
10. Tatsuya I., Mitsuyasu T., and Yoshihiro T. Optical coherence tomography analysis of neointimal stent coverage in sirolimus eluting stents compared with bare metal stents. American College of Cardiology Scientific Sessions 2006. J Am Coll Cardiol 47 Suppl (2006) A2906-A2973
11. Tanigawa J., Barlis P., and Di Mario C. Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention 3 (2007) 128-136
12. Tanigawa J., Barlis P., Dimopoulos K., Dalby M., Moore P., and Di Mario C. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. Int J Cardiol (2008) Sep 3 [Epub ahead of print]
13. Giordana S., Sherwin S.J., Peiro J., et al. Automated classification of peripheral distal by-pass geometries reconstructed from medical data. J Biomech 38 (2005) 47-62
14. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
15. Chen B.X., Ma F.Y., Wei L., et al. Neointimal coverage of bare metal and sirolimus-eluting stents evaluated with optical coherence tomography. Heart 94 (2008) 566-570
16. Takano M., Inami S., Jang I.K., et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 99 (2007) 1033-1038
17. Matsumoto D., Shite J., Shinke T., et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28 (2007) 961-967
18. Hausleiter J., Kastrati A., Wessely R., et al. Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free on-site stent coating. Eur Heart J 26 (2005) 1475-1481
19. Mehilli J., Kastrati A., Wessely R., et al. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss. Circulation 113 (2006) 273-279
20. Ruef J., Storger H., Schwarz F., et al. Comparison of a polymer-free rapamycin-eluting stent (Yukon) with a polymer-based paclitaxel-eluting stent (Taxus) in real-world coronary artery lesions. Catheter Cardiovasc Interv 71 (2008) 333-339
21. Finn A., Nakazawa G., Joner M., et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioslcer Thromb Vasc Biol 27 (2007) 1500-1510